Danut, a Korean conglomerate, acquired a biotech firm with a produce-ripening chemical that works especially well with apples. Using Maine as a test market, the case requires determining whether to commercialize by calculating total addressable market, quantifying benefits to farmers, and determining optimal pricing to capture value.
Key Insights:
- Market sizing shows $600M TAM (200 orchards × 100 acres × $30K/acre), which is substantial and warrants investigation
- Total value to farmers is $2,025/acre annually ($150 cost savings + $750 from improved yield + $1,125 from sweetness improvement)
- At $500/acre product cost, a $1,000/acre price captures 50% of farmer benefits while maintaining farmer profitability (75% margin to farmer)
- Beyond financial metrics, qualitative risks matter: differentiation/positioning, environmental/regulatory concerns, patenting, operational capacity, and strategic fit to Danut’s portfolio